Lv4
420 积分 2026-06-08 加入
Ribociclib-Letrozole Combination as an Alternative for Neoadjuvant Chemotherapy in Selected Postmenopausal Patients with Luminal Breast Cancer (BOOG 2017-01)
5小时前
待确认
Association Between Tumor Size and Nodal Positivity for HER2+ and Triple-Negative Early-Stage Breast Cancer: A Population-Based Study
4天前
已完结
The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer
21天前
已完结
Adding Ovarian Suppression to Tamoxifen for Premenopausal Women With Hormone Receptor-Positive Breast Cancer After Chemotherapy: An 8-Year Follow-Up of the ASTRRA Trial
25天前
已完结
Abstract GS4-02: Randomized comparison of adjuvant aromatase inhibitor exemestane (E) plus ovarian function suppression (OFS) vs tamoxifen (T) plus OFS in premenopausal women with hormone receptor positive (HR+) early breast cancer (BC): Update of the combined TEXT and SOFT trials
1个月前
已关闭
Preparation and in vitro/in vivo evaluation of uniform-sized Goserelin-loaded sustained release microspheres
1个月前
已完结
Immunotherapy resistance in triple-negative breast cancer: Mechanisms and emerging therapeutic strategies
2个月前
已完结
Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3
2个月前
已完结
皖公网安备34019202002308
